Crinetics Pharmaceuticals (CRNX) News Today $35.50 -1.00 (-2.74%) As of 02:29 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock CRNX Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Parkman Healthcare Partners LLC Boosts Holdings in Crinetics Pharmaceuticals, Inc. $CRNXSeptember 8 at 7:45 AM | marketbeat.comCormorant Asset Management LP Sells 400,000 Shares of Crinetics Pharmaceuticals, Inc. $CRNXSeptember 6, 2025 | marketbeat.comAWM Investment Company Inc. Acquires 40,000 Shares of Crinetics Pharmaceuticals, Inc. $CRNXSeptember 5, 2025 | marketbeat.comCrinetics Pharmaceuticals (NASDAQ:CRNX) Trading 6.1% Higher - Time to Buy?September 4, 2025 | marketbeat.comCrinetics Pharmaceuticals, Inc. $CRNX Shares Sold by First Light Asset Management LLCSeptember 4, 2025 | marketbeat.comVestal Point Capital LP Purchases Shares of 1,500,000 Crinetics Pharmaceuticals, Inc. $CRNXSeptember 4, 2025 | marketbeat.comCrinetics Pharmaceuticals, Inc. $CRNX Shares Purchased by MPM Bioimpact LLCSeptember 4, 2025 | marketbeat.comCrinetics: Low Expectations As The PDUFA Clock Ticks To ZeroSeptember 3, 2025 | seekingalpha.comParadigm Biocapital Advisors LP Acquires 35,407 Shares of Crinetics Pharmaceuticals, Inc. $CRNXSeptember 2, 2025 | marketbeat.com18,800 Shares in Crinetics Pharmaceuticals, Inc. $CRNX Bought by Jump Financial LLCSeptember 2, 2025 | marketbeat.comNorthern Trust Corp Sells 22,733 Shares of Crinetics Pharmaceuticals, Inc. $CRNXSeptember 2, 2025 | marketbeat.comCrinetics Pharmaceuticals, Inc. $CRNX Shares Bought by Rafferty Asset Management LLCSeptember 1, 2025 | marketbeat.comInvesco Ltd. Sells 228,295 Shares of Crinetics Pharmaceuticals, Inc. $CRNXSeptember 1, 2025 | marketbeat.comCrinetics Pharmaceuticals, Inc. $CRNX Shares Acquired by Driehaus Capital Management LLCAugust 31, 2025 | marketbeat.comCrinetics Pharmaceuticals, Inc. $CRNX Stock Position Raised by Siren L.L.C.August 31, 2025 | marketbeat.comWalleye Capital LLC Reduces Stock Holdings in Crinetics Pharmaceuticals, Inc. $CRNXAugust 29, 2025 | marketbeat.comMartingale Asset Management L P Sells 15,783 Shares of Crinetics Pharmaceuticals, Inc. $CRNXAugust 29, 2025 | marketbeat.comAffinity Asset Advisors LLC Has $5.11 Million Stock Holdings in Crinetics Pharmaceuticals, Inc. $CRNXAugust 28, 2025 | marketbeat.comDana Pizzuti Sells 30,000 Shares of Crinetics Pharmaceuticals (NASDAQ:CRNX) StockAugust 27, 2025 | insidertrades.comPrice T Rowe Associates Inc. MD Sells 302,145 Shares of Crinetics Pharmaceuticals, Inc. $CRNXAugust 27, 2025 | marketbeat.comT. Rowe Price Investment Management Inc. Sells 313,617 Shares of Crinetics Pharmaceuticals, Inc. $CRNXAugust 26, 2025 | marketbeat.comAmerican Century Companies Inc. Raises Holdings in Crinetics Pharmaceuticals, Inc. $CRNXAugust 25, 2025 | marketbeat.comEntryPoint Capital LLC Makes New $315,000 Investment in Crinetics Pharmaceuticals, Inc. $CRNXAugust 24, 2025 | marketbeat.comRussell Investments Group Ltd. Has $5.58 Million Stock Holdings in Crinetics Pharmaceuticals, Inc. $CRNXAugust 24, 2025 | marketbeat.comCandriam S.C.A. Takes Position in Crinetics Pharmaceuticals, Inc. $CRNXAugust 23, 2025 | marketbeat.comAberdeen Group plc Purchases 164,670 Shares of Crinetics Pharmaceuticals, Inc. $CRNXAugust 23, 2025 | marketbeat.comCrinetics Pharmaceuticals (NASDAQ:CRNX) Insider Dana Pizzuti Sells 6,492 SharesAugust 22, 2025 | insidertrades.comWellington Management Group LLP Has $231.14 Million Holdings in Crinetics Pharmaceuticals, Inc. $CRNXAugust 22, 2025 | marketbeat.comNuveen LLC Buys New Stake in Crinetics Pharmaceuticals, Inc. $CRNXAugust 22, 2025 | marketbeat.comCrinetics receives Orphan Drug designation for atumelnant in CAHAugust 21, 2025 | msn.comCrinetics Pharmaceuticals Receives FDA Orphan Drug Designation for Atumelnant in Treating Classic Congenital Adrenal HyperplasiaAugust 21, 2025 | quiverquant.comQCrinetics Receives FDA Orphan Drug Designation for Atumelnant in the Treatment of Congenital Adrenal Hyperplasia (CAH)August 21, 2025 | globenewswire.comVanguard Group Inc. Grows Position in Crinetics Pharmaceuticals, Inc. $CRNXAugust 19, 2025 | marketbeat.comCrinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Given Consensus Recommendation of "Moderate Buy" by AnalystsAugust 17, 2025 | marketbeat.comCrinetics Pharmaceuticals, Inc.: Crinetics Pharmaceuticals Announces August 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)August 13, 2025 | finanznachrichten.deJonesTrading Reaffirms Their Buy Rating on Crinetics Pharmaceuticals (CRNX)August 13, 2025 | theglobeandmail.comCrinetics Pharmaceuticals (CRNX) Receives a Buy from Evercore ISIAugust 13, 2025 | theglobeandmail.comCrinetics Pharma’s Earnings Call: Progress Amid ChallengesAugust 13, 2025 | msn.comJMP Securities Cuts Crinetics Pharmaceuticals (NASDAQ:CRNX) Price Target to $86.00August 12, 2025 | marketbeat.comCrinetics Pharmaceuticals Announces August 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)August 11, 2025 | globenewswire.comH.C. Wainwright Keeps Their Buy Rating on Crinetics Pharmaceuticals (CRNX)August 9, 2025 | theglobeandmail.comMorgan Stanley Reaffirms Their Buy Rating on Crinetics Pharmaceuticals (CRNX)August 9, 2025 | theglobeandmail.comCrinetics Pharmaceuticals, Inc. (CRNX) Q2 2025 Earnings Call TranscriptAugust 9, 2025 | seekingalpha.comCrinetics (CRNX) Q2 Revenue Jumps 150%August 7, 2025 | fool.comCrinetics Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Business UpdateAugust 7, 2025 | globenewswire.comTD Asset Management Inc Decreases Stake in Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX)August 3, 2025 | marketbeat.comCrinetics Pharmaceuticals (CRNX) to Release Earnings on ThursdayAugust 1, 2025 | marketbeat.comCrinetics Pharmaceuticals, Inc. (CRNX)’ Oral Acromegaly Drug Nears FDA Decision After Strong Phase 3 DataJuly 31, 2025 | msn.comDecheng Capital LLC Has $5.97 Million Stock Holdings in Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX)July 30, 2025 | marketbeat.comFiera Capital Corp Sells 16,645 Shares of Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX)July 30, 2025 | marketbeat.com Get Crinetics Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CRNX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CRNX Media Mentions By Week CRNX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CRNX News Sentiment▼1.330.84▲Average Medical News Sentiment CRNX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CRNX Articles This Week▼87▲CRNX Articles Average Week Get the Latest News and Ratings for CRNX and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Crinetics Pharmaceuticals and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Ascendis Pharma A/S News Today Viatris News Today Dr. Reddy's Laboratories News Today QIAGEN News Today BridgeBio Pharma News Today Moderna News Today Verona Pharma PLC American Depositary Share News Today Elanco Animal Health News Today Roivant Sciences News Today Revolution Medicines News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CRNX) was last updated on 9/10/2025 by MarketBeat.com Staff From Our PartnersWall Street legend: “Put $1,000 in this AI stock”A massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | Sponsored“HELIOS”: My No. 1 Investment of the 2020sA mysterious new energy technology — backed by Nvidia, Google, and even legendary investors like Stanley Druck...Stansberry Research | SponsoredThe Obscure Korean War Act That Created a $5.39 Billion Passive Income StreamAn obscure Korean War law has just been enacted by the U.S. government... Allowing it to take a heavy hand ...Angel Publishing | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredTrump’s reported death a hoaxHow Trump’s latest policies could trigger a full-scale debt collapse… And the specific investments that cou...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Crinetics Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Crinetics Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CRNX Stock Alerts